Tonantzitlolone is a nanomolar potency activator of transient receptor potential canonical 1/4/5 channels. (2018)
Attributed to:
Maximising patient benefit: Leeds’ Interdisciplinary approach to translation (CiC 2017)
funded by
UKRI
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1111/bph.14379
PubMed Identifier: 29859013
Publication URI: http://europepmc.org/abstract/MED/29859013
Type: Journal Article/Review
Volume: 175
Parent Publication: British journal of pharmacology
Issue: 16
ISSN: 0007-1188